查看购物车
  • Traditional Chinese
  • English
2021-2031年亚太地区抗生素和抗真菌药物市场报告：范围、细分、动态和竞争分析
市场调查报告书
商品编码
1871449

2021-2031年亚太地区抗生素和抗真菌药物市场报告：范围、细分、动态和竞争分析

Asia Pacific Antibiotics & Antimycotics Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 191 Pages | 订单完成后即时交付

价格

预计亚太地区抗生素和抗真菌药物市场将显着成长，到 2031 年将达到约 405.4575 亿美元，高于 2023 年的 265.7038 亿美元，反映出 2023 年至 2031 年预测期内的年复合成长率为 5.4%。

执行摘要和市场分析

该市场分为几个主要区域，包括中国、日本、印度、韩国、澳洲以及亚太其他地区。推动该市场成长的主要因素是该地区细菌和真菌感染（例如肺炎、泌尿道感染、性传染病和皮肤感染）发病率的上升。此外，市场参与者的策略性倡议，包括新产品的推出和审批，预计将在未来几年为市场扩张创造丰厚的机会。

市场区隔

亚太地区抗生素和抗真菌药物市场可以透过多种细分市场进行分析，包括药物类别、适应症、给药途径和配销通路：

  • 药物类别：市场将药物分为多个类别，包括青霉素类、头孢菌素类、碳青霉烯类、大环内酯类、氨基糖苷类、喹诺酮类、磺胺类、四环素类、唑类等。 2023年，头孢菌素类占据最大的市场份额。
  • 适应症：市场根据适应症进行细分，例如皮肤感染、呼吸道感染、泌尿道感染、败血症、耳部感染、胃肠道感染等。 2023年，皮肤感染占最大市场份额。
  • 给药途径：市场分为口服、外用和其他给药途径，其中口服给药在 2023 年最为常见。
  • 配销通路：分销管道包括医院药房、零售药房和线上药房，其中医院药房在 2023 年占据市场份额领先地位。

市场展望

人们对真菌感染及其健康影响的认识不断提高，加之政府和私营部门的积极倡议，是推动抗生素和抗真菌药物市场成长的重要因素。全球真菌感染行动基金（GAFFI）报告称，全球有超过3亿人患有严重的真菌疾病，每年导致约150万人死亡，超过疟疾和结核病死亡人数的总和。如此惊人的盛行率促使人们加强教育和诊断工作，提高医护人员和病患对及时治疗必要性的认识。

分子检测等诊断方法的创新提高了真菌病原体的早期检出率，进一步增加了对有效抗真菌治疗的需求。全球真菌病防治联合会（GAFFI）于2015年制定的「消除真菌疾病十年路线图」概述了有效诊断的关键条件。包括国际人类和动物真菌学会（ISHAM）和欧洲疾病预防控制中心（ECDC）在内的多个组织正积极致力于提高公众对真菌感染负担的认识，并推广预防、诊断和治疗策略。每年9月16日至20日举行的「真菌疾病宣传週」旨在提高公众对真菌疾病日益普遍以及采取适当应对措施必要性的认识。

国家概况

亚太地区抗生素和抗真菌药物市场按国家/地区进行了进一步分析，其中中国在2023年占据最大的市场份额。中国真菌和细菌感染（例如泌尿道感染和肺炎）的发生率不断上升，这推动了对抗生素和抗真菌药物的需求。根据《流行病学与感染杂誌》2023年的数据，中国每年约有2,110万人感染社区型肺炎（CAP）。中国常用的抗生素包括青霉素类、氟喹诺酮类、头孢菌素类和硝基咪唑类。

市场参与者的策略性倡议，包括产品发布和研发，预计将创造显着的成长机会。例如，2024年9月，广州中以生物产业投资基金2期有限责任合伙企业向BioVersys投资600万美元，用于支持其靶向耐碳青霉烯类鲍曼不动桿菌的药物BV100在中国开展临床试验。 2023年3月，珠峰医药（Everest Medicines）的药物Xerava（依拉环素）获得中国国家药品监督管理局的新药申请批准，用于治疗成人复杂性腹腔内感染。

公司简介

抗生素和抗真菌药物市场的主要参与者包括辉瑞公司、诺华公司、赛诺菲公司、罗氏公司、默克公司、葛兰素史克公司、强生公司、西普拉公司、拜耳公司、艾伯维公司和安斯泰来製药公司。这些公司正在采用各种策略，例如扩张、产品创新以及併购，以增强其市场份额并为消费者提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：

第四章：亚太地区抗生素和抗真菌药物市场－主要市场动态

  • 市场驱动因素
    • 传染病发生率不断上升
    • 人们对真菌感染的认识不断提高
  • 市场限制
    • 抗菌素抗药性、经济障碍和繁琐的监管程序
  • 市场机会
    • 持续的资金投入与研发计划
  • 未来趋势
    • 产品开发和治疗输送方法的技术进步
  • 驾驶员和安全带的影响：

第五章：抗生素和抗真菌药物市场—亚太地区分析

  • 2021-2031年亚太地区抗生素及抗霉菌药物市场收入
  • 亚太地区抗生素和抗真菌药物市场预测分析

第六章：亚太地区抗生素与抗霉菌药物市场分析－依药物类别划分

  • 青霉素
  • 头孢菌素
  • 碳青霉烯类
  • 大环内酯类
  • 氨基糖苷类
  • 奎诺酮类
  • 磺胺类药物
  • 四环素类
  • 唑类
  • 其他的

第七章：亚太地区抗生素和抗真菌药物市场分析－依适应症划分

  • 皮肤感染
  • 呼吸道感染
  • 泌尿道感染（UTI）
  • 败血症
  • 耳部感染
  • 胃肠道感染
  • 其他的

第八章：亚太地区抗生素和抗真菌药物市场分析－按给药途径划分

  • 口服
  • 主题
  • 其他的

第九章：亚太地区抗生素和抗真菌药物市场分析－按配销通路划分

  • 医院药房
  • 零售药局
  • 网路药局

第十章：亚太地区抗生素与抗霉菌药物市场－国别分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太其他地区

第十一章：抗生素和抗真菌药物市场——产业概况

  • 概述
  • 抗生素和抗真菌药物市场成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章：公司简介

  • Pfizer Inc
  • Novartis AG
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd
  • Merck & Co Inc
  • GSK Plc
  • Johnson & Johnson
  • Cipla Ltd
  • Bayer AG
  • AbbVie Inc
  • Astellas Pharma Inc

第十三章：附录

Product Code: BMIRE00032106

The Asia Pacific antibiotics and antimycotics market is projected to grow significantly, reaching approximately US$ 40,545.75 million by 2031, up from US$ 26,570.38 million in 2023, reflecting a compound annual growth rate (CAGR) of 5.4% during the forecast period from 2023 to 2031.

Executive Summary and Market Analysis

The market is divided into several key regions, including China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of this market is primarily driven by the rising incidence of bacterial and fungal infections, such as pneumonia, urinary tract infections (UTIs), sexually transmitted diseases, and skin infections across the region. Additionally, strategic initiatives by market players, including new product launches and approvals, are expected to create lucrative opportunities for market expansion in the coming years.

Market Segmentation

The Asia Pacific antibiotics and antimycotics market can be analyzed through various segments, including drug class, indication, route of administration, and distribution channel:

  • Drug Class: The market is categorized into several drug classes, including penicillin, cephalosporins, carbapenems, macrolides, aminoglycosides, quinolones, sulfonamides, tetracyclines, azoles, and others. In 2023, cephalosporins held the largest market share.
  • Indication: The market is segmented based on indications such as skin infections, respiratory infections, UTIs, septicemia, ear infections, gastrointestinal infections, and others. Skin infections accounted for the largest share in 2023.
  • Route of Administration: The market is divided into oral, topical, and other routes of administration, with oral administration being the most prevalent in 2023.
  • Distribution Channel: The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with hospital pharmacies leading the market share in 2023.

Market Outlook

The increasing awareness of fungal infections and their health implications, along with initiatives from both government and private sectors, are significant factors contributing to the growth of the antibiotics and antimycotics market. The Global Action Fund for Fungal Infections (GAFFI) reported that over 300 million people globally suffer from serious fungal diseases, leading to approximately 1.5 million deaths annually, surpassing the combined fatalities from malaria and tuberculosis. This alarming prevalence has prompted enhanced educational efforts and diagnostic initiatives, raising awareness among healthcare providers and patients about the critical need for timely treatment.

Innovations in diagnostic methods, such as molecular testing, have improved the early detection of fungal pathogens, further increasing the demand for effective antifungal treatments. GAFFI's 10-year roadmap for eliminating fungal diseases, established in 2015, outlines essential conditions for effective diagnostic delivery. Various organizations, including the International Society for Human and Animal Mycology (ISHAM) and the European Centre for Disease Prevention and Control (ECDC), are actively working to highlight the burden of fungal infections, promoting prevention, diagnosis, and treatment strategies. The annual Fungal Disease Awareness Week, observed from September 16-20, aims to raise awareness about the growing prevalence of fungal diseases and the need for appropriate responses.

Country Insights

The Asia Pacific antibiotics and antimycotics market is further analyzed by country, with China holding the largest market share in 2023. The country is witnessing a rising prevalence of fungal and bacterial infections, such as UTIs and pneumonia, which drives the demand for antibiotics and antimycotics. According to the Epidemiology and Infection Journal 2023, around 21.1 million individuals in China are affected by community-acquired pneumonia (CAP) annually. Commonly used antibiotics in China include penicillins, fluoroquinolones, cephalosporins, and nitroimidazoles.

Strategic initiatives by market players, including product launches and developments, are expected to create significant growth opportunities. For example, in September 2024, Guangzhou Sino-Israel Bio-Industry Investment Fund 2 LLP invested US$ 6.0 million in BioVersys to support clinical trials in China for BV100, targeting carbapenem-resistant Acinetobacter baumannii. In March 2023, Everest Medicines received a New Drug Application from China's National Medical Products Administration for Xerava (eravacycline) to treat complex intra-abdominal infections in adults.

Company Profiles

Key players in the antibiotics and antimycotics market include Pfizer Inc., Novartis AG, Sanofi SA, F. Hoffmann-La Roche Ltd, Merck & Co Inc., GSK Plc, Johnson & Johnson, Cipla Ltd, Bayer AG, AbbVie Inc., and Astellas Pharma Inc. These companies are employing various strategies, such as expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Infectious Diseases
    • 4.1.2 Growing Awareness About Fungal Infections
  • 4.2 Market Restraints
    • 4.2.1 Antimicrobial Resistance, Financial Barriers, and Extensive Regulatory Processes
  • 4.3 Market Opportunities
    • 4.3.1 Ongoing Funding and Research & Development Initiatives
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Product Development and Treatment Delivery Approaches
  • 4.5 Impact of Drivers and Restraints:

5. Antibiotics and Antimycotics Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Antibiotics and Antimycotics Market Forecast Analysis

6. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Drug Class

  • 6.1 Penicillin
    • 6.1.1 Overview
    • 6.1.2 Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Cephalosporines
    • 6.2.1 Overview
    • 6.2.2 Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Carbapenems
    • 6.3.1 Overview
    • 6.3.2 Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Macrolides
    • 6.4.1 Overview
    • 6.4.2 Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Aminoglycosides
    • 6.5.1 Overview
    • 6.5.2 Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Quinolones
    • 6.6.1 Overview
    • 6.6.2 Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 Sulfonamides
    • 6.7.1 Overview
    • 6.7.2 Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Tetracyclines
    • 6.8.1 Overview
    • 6.8.2 Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.9 Azoles
    • 6.9.1 Overview
    • 6.9.2 Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.10 Others
    • 6.10.1 Overview
    • 6.10.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Indication

  • 7.1 Skin Infections
    • 7.1.1 Overview
    • 7.1.2 Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Respiratory Infections
    • 7.2.1 Overview
    • 7.2.2 Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Urinary Tract Infections (UTI)
    • 7.3.1 Overview
    • 7.3.2 Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Septicemia
    • 7.4.1 Overview
    • 7.4.2 Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Ear Infections
    • 7.5.1 Overview
    • 7.5.2 Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Gastrointestinal Infections
    • 7.6.1 Overview
    • 7.6.2 Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Topical
    • 8.2.1 Overview
    • 8.2.2 Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Overview
    • 9.1.2 Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Online Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Antibiotics and Antimycotics Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Antibiotics and Antimycotics Market Overview
    • 10.1.2 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.1 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.2 China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.2.1 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.2.2 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.2.3 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.2.4 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.3 Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.3.1 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.3.2 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.3.3 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.3.4 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.4 India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.4.1 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.4.2 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.4.3 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.4.4 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.5 Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.5.1 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.5.2 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.5.3 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.5.4 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.6 South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.6.1 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.6.2 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.6.3 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.6.4 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.7 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.7.1 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.7.2 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.7.3 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.7.4 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

11. Antibiotics and Antimycotics Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Antibiotics and Antimycotics Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Pfizer Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Novartis AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sanofi SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 F. Hoffmann-La Roche Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Merck & Co Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 GSK Plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Johnson & Johnson
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Cipla Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bayer AG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 AbbVie Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Astellas Pharma Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation
  • Table 2. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Drug Class
  • Table 4. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Indication
  • Table 5. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Route of Administration
  • Table 6. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Distribution Channel
  • Table 7. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 8. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 9. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 10. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 11. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 12. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 13. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 14. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 15. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 16. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 17. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 18. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 19. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 20. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 21. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 22. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 23. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 24. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 25. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 26. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 27. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 28. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 29. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 30. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 31. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 32. Recent Organic Growth Strategies in Antibiotics and Antimycotics Market
  • Table 33. Recent Inorganic Growth Strategies in the Antibiotics and Antimycotics Market
  • Table 34. Glossary of Terms, Antibiotics and Antimycotics Market

List Of Figures

  • Figure 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation - Country
  • Figure 2. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Drug Class (2023 and 2031)
  • Figure 6. Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Indication (2023 and 2031)
  • Figure 17. Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Route of Administration (2023 and 2031)
  • Figure 25. Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Distribution Channel (2023 and 2031)
  • Figure 29. Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Asia Pacific Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 34. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 35. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 36. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 39. Growth Strategies in Antibiotics and Antimycotics Market